v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Total revenues $ 237,577 $ 329,219
Costs and expenses:    
Selling, general and administrative 75,642 117,537
Research and development 32,605 18,312
Contingent consideration 136 (106)
Amortization of intangible assets 21,474 22,025
Total costs and expenses 268,171 401,643
Operating loss (30,594) (72,424)
Other income and (expense), net:    
Interest income 1,030 10
Interest expense (3,391) (2,662)
Fair value changes of derivative instruments, net (1,059) (132)
Other income (expense), net 17,017 (1,442)
Other income (expense), net 13,597 (4,226)
Loss before income taxes and investment losses (16,997) (76,650)
Income tax benefit (provision) (1,233) 21,266
Net loss before investment losses (18,230) (55,384)
Loss from investments in investees (37) (49)
Net loss $ (18,267) $ (55,433)
Loss per share, basic and diluted:    
Loss per share, basic (in dollars per share) $ (0.02) $ (0.08)
Loss per share, diluted (in dollars per share) $ (0.02) $ (0.08)
Weighted average common shares outstanding, basic (in shares) 751,506,257 660,302,426
Weighted average common shares outstanding, diluted (in shares) 751,506,257 660,302,426
Services    
Revenues:    
Total revenues $ 132,368 $ 286,599
Costs and expenses:    
Cost of service revenue 114,059 221,202
Products    
Revenues:    
Total revenues 40,383 36,658
Costs and expenses:    
Cost of service revenue 24,255 22,673
Revenue from transfer of intellectual property and other    
Revenues:    
Total revenues $ 64,826 $ 5,962

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL